RAMIRO
JOVER ATIENZA
CATEDRÁTICO/A DE UNIVERSIDAD
Instituto de Investigación Sanitaria La Fe
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria La Fe (33)
2024
-
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways
International Journal of Molecular Sciences, Vol. 25, Núm. 10
-
Idiosyncratic Drug-Induced Liver Injury and Amoxicillin–Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients
International Journal of Molecular Sciences, Vol. 25, Núm. 13
2023
-
Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference
Analyst, Vol. 148, Núm. 13, pp. 3097-3106
2022
-
Elimination of Vitamin D Signaling Causes Increased Mortality in a Model of Overactivation of the Insulin Receptor: Role of Lipid Metabolism
Nutrients, Vol. 14, Núm. 7
-
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
Antioxidants, Vol. 11, Núm. 5
-
PTEN Deletion in Adult Mice Induces Hypoinsulinemia With Concomitant Low Glucose Levels
Frontiers in Endocrinology, Vol. 13
-
Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat
International journal of molecular sciences, Vol. 23, Núm. 16
-
The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes
Communications Biology, Vol. 5, Núm. 1
2021
-
Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways
Food and Chemical Toxicology, Vol. 158
-
The synbiotic combination of akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation
Antioxidants, Vol. 10, Núm. 12
2020
-
A novel MicroRNA signature for cholestatic drugs in human hepatocytes and its translation into novel circulating biomarkers for drug-induced liver injury patients
Toxicological Sciences, Vol. 173, Núm. 2, pp. 229-243
-
Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes
Archives of Toxicology, Vol. 94, Núm. 2, pp. 589-607
-
The vitamin D receptor regulates glycerolipid and phospholipid metabolism in human hepatocytes
Biomolecules, Vol. 10, Núm. 3
-
Toward Rapid Screening of Liver Grafts at the Operating Room Using Mid-infrared Spectroscopy
Analytical Chemistry, Vol. 92, Núm. 21, pp. 14542-14549
2019
-
A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease
Molecular Nutrition and Food Research, Vol. 63, Núm. 20
-
Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice
Molecular Nutrition and Food Research, Vol. 63, Núm. 8
2018
-
Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems
Food and Chemical Toxicology, Vol. 120, pp. 196-212
-
Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis
American Journal of Pathology, Vol. 188, Núm. 12, pp. 2800-2810
-
Non-invasive prediction of NAFLD severity: A comprehensive, independent validation of previously postulated serum microRNA biomarkers
Scientific Reports, Vol. 8, Núm. 1
-
Predicting drug-induced cholestasis: preclinical models
Expert Opinion on Drug Metabolism and Toxicology, Vol. 14, Núm. 7, pp. 721-738